Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Hybridoma cell lines (my-C-CC0C2-235-3H8) and use thereof for producing a monoclonal antibody against the human cardiac myosin binding protein C (C-protein, MYBPC3, CMYBP-C or MY-C)

US Patent 9975961 · Granted May 22, 2018

Assignee

Inventors

View full patent text on Google Patents →